Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Defrancesco

Showing results (111-120 of 156) with videos related to

Pageof 16
Sort By:
Nature Biotechnology|September 7, 2018
Q218-public flotation jackpotLaura DeFrancesco
Nature Biotechnology|August 7, 2018
Drug pipeline: 2Q18Laura DeFrancesco
Nature Biotechnology|June 8, 2017
Hanging on a threadLaura DeFrancesco
Nature Biotechnology|June 7, 2018
1Q18-the risk-capital roll continuesLaura DeFrancesco
Nature Biotechnology|August 19, 2025
Mitochondrial transplants make healthy babiesLaura DeFrancesco
Nature Biotechnology|August 9, 2022
Drug pipeline 2Q22 - a downturn in approvalsLaura DeFrancesco
Nature Biotechnology|August 9, 2022
2Q22 - Slip sliding awayLaura DeFrancesco
Nature Biotechnology|August 12, 2022
Abalos Therapeutics---arenaviruses take on cancerLaura DeFrancesco
Nature Biotechnology|November 8, 2022
3Q22 - more malaise in the marketsLaura DeFrancesco
Nature Biotechnology|March 11, 2011
Five more years of Nature Biotechnology researchMonya Baker, Laura DeFrancesco
Pageof 16

Showing results (111-120 of 156) with videos related to

Sort By:
Pageof 16
Nature Biotechnology|September 7, 2018
Q218-public flotation jackpotLaura DeFrancesco
Nature Biotechnology|August 7, 2018
Drug pipeline: 2Q18Laura DeFrancesco
Nature Biotechnology|June 8, 2017
Hanging on a threadLaura DeFrancesco
Nature Biotechnology|June 7, 2018
1Q18-the risk-capital roll continuesLaura DeFrancesco
Nature Biotechnology|August 19, 2025
Mitochondrial transplants make healthy babiesLaura DeFrancesco
Nature Biotechnology|August 9, 2022
Drug pipeline 2Q22 - a downturn in approvalsLaura DeFrancesco
Nature Biotechnology|August 9, 2022
2Q22 - Slip sliding awayLaura DeFrancesco
Nature Biotechnology|August 12, 2022
Abalos Therapeutics---arenaviruses take on cancerLaura DeFrancesco
Nature Biotechnology|November 8, 2022
3Q22 - more malaise in the marketsLaura DeFrancesco
Nature Biotechnology|March 11, 2011
Five more years of Nature Biotechnology researchMonya Baker, Laura DeFrancesco
Pageof 16